Literature DB >> 11206646

Long-term survivors after the resection of limited esophageal small cell carcinoma.

M Mitani1, Y Kuwabara, N Shinoda, A Sato, Y Fujii.   

Abstract

Patients with small cell carcinoma of the esophagus have a poor prognosis and have generally been treated by chemotherapy. However, all reported cases were at advanced stages. We need to establish an adequate treatment for patients with small cell carcinoma of the esophagus with invasion limited to the submucosal layer. In this paper, five cases of small cell carcinomas, which accounted for 2.8% of 180 surgically treated esophageal carcinomas, were reviewed for pathological findings, treatment, and outcome. Among three patients who had a small cell carcinoma of the esophagus with invasion limited to the submucosal layer, two patients survived for 7 and 9 years after surgery with no evidence of the disease. One of them was treated using surgery alone. Consequently, surgery may be considered as a possible choice of treatment for small cell carcinoma of the esophagus with invasion limited to the submucosa.

Entities:  

Mesh:

Year:  2000        PMID: 11206646     DOI: 10.1046/j.1442-2050.2000.00124.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  10 in total

Review 1.  Primary small cell carcinoma of esophagus: report of 9 cases and review of literature.

Authors:  Zhu Wu; Jian-Yang Ma; Jun-Jie Yang; Yong-Fan Zhao; Shang-Fu Zhang
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

2.  A rare cause of the cough: primary small cell carcinoma of esophagus-case report.

Authors:  Erdal Yekeler; Timur Koca; Semra Vural
Journal:  Case Rep Med       Date:  2012-02-22

3.  Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma.

Authors:  Huan-Huan Wang; Nicholas G Zaorsky; Mao-Bin Meng; Zhi-Qiang Wu; Xian-Liang Zeng; Bo Jiang; Chao Jiang; Lu-Jun Zhao; Zhi-Yong Yuan; Ping Wang
Journal:  Onco Targets Ther       Date:  2015-02-13       Impact factor: 4.147

Review 4.  Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review.

Authors:  Emma Elizabeth Ilett; Seppo W Langer; Ingrid Holst Olsen; Birgitte Federspiel; Andreas Kjær; Ulrich Knigge
Journal:  Diagnostics (Basel)       Date:  2015-04-08

5.  The clinicopathologic features and prognosis of esophageal neuroendocrine carcinomas: a single-center study of 53 resection cases.

Authors:  Lei Ye; Heng Lu; Lin Wu; Lei Zhang; Hui Shi; Hui Min Wu; Pin Tu; De Min Li; Fang Yu Wang
Journal:  BMC Cancer       Date:  2019-12-18       Impact factor: 4.430

6.  Use of Chemoradiotherapy as a Treatment Option for Patients with Limited-Stage Primary Small Cell Carcinoma of the Esophagus.

Authors:  Kaikai Zhao; Zhaoqin Huang; Youjiao Si; Liangchao Sun; Jinming Yu; Xiangjiao Meng
Journal:  Cancer Manag Res       Date:  2021-01-25       Impact factor: 3.989

7.  Limited stage small cell carcinoma of the gastrointestinal tract: a clinicopathologic and prognostic analysis of 27 cases.

Authors:  Chunyan Peng; Shanshan Shen; Xiaoqi Zhang; Xiaoping Zou
Journal:  Rare Tumors       Date:  2013-05-02

8.  Primary colorectal small cell carcinoma: a clinicopathological and immunohistochemical study of 10 cases.

Authors:  Dina El Demellawy; Mahmoud A Khalifa; Nadia Ismiil; Shun Wong; Zeina Ghorab
Journal:  Diagn Pathol       Date:  2007-09-05       Impact factor: 2.644

9.  The 2002 AJCC TNM classification is a better predictor of primary small cell esophageal carcinoma outcome than the VALSG staging system.

Authors:  Sheng-Ye Wang; Wei-Ming Mao; Xiang-Hui Du; Ya-Ping Xu; Su-Zhan Zhang
Journal:  Chin J Cancer       Date:  2012-10-10

10.  Adjuvant Therapeutic Modalities in Primary Small Cell Carcinoma of Esophagus Patients: A Retrospective Cohort Study of Multicenter Clinical Outcomes.

Authors:  Bingwen Zou; Tao Li; Qiang Zhou; Daiyuan Ma; Yongshun Chen; Meijuan Huang; Feng Peng; Yong Xu; Jiang Zhu; Zhenyu Ding; Lin Zhou; Jin Wang; Li Ren; Min Yu; Youling Gong; Yanying Li; Longqi Chen; You Lu
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.